These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FOXO1 and GSK-3β Are Main Targets of Insulin-Mediated Myogenesis in C2C12 Muscle Cells. Litwiniuk A, Pijet B, Pijet-Kucicka M, Gajewska M, Pająk B, Orzechowski A. PLoS One; 2016; 11(1):e0146726. PubMed ID: 26785133 [Abstract] [Full Text] [Related]
3. Interleukin-6 Induces Myogenic Differentiation via JAK2-STAT3 Signaling in Mouse C2C12 Myoblast Cell Line and Primary Human Myoblasts. Steyn PJ, Dzobo K, Smith RI, Myburgh KH. Int J Mol Sci; 2019 Oct 24; 20(21):. PubMed ID: 31652937 [Abstract] [Full Text] [Related]
4. Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation. van der Velden JL, Langen RC, Kelders MC, Wouters EF, Janssen-Heininger YM, Schols AM. Am J Physiol Cell Physiol; 2006 Feb 24; 290(2):C453-62. PubMed ID: 16162663 [Abstract] [Full Text] [Related]
7. [APPL1-mediated effects of leptin on activity of GSK-3β in C2C12 cell]. Xu M, Xiao YY, Han JF, Yin J, Lu JX, Liu RB, Wei L, Bao YQ, Jia WP. Zhonghua Yi Xue Za Zhi; 2013 May 14; 93(18):1432-6. PubMed ID: 24025512 [Abstract] [Full Text] [Related]
8. Estrogen-related receptor α regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway. Murray J, Huss JM. Am J Physiol Cell Physiol; 2011 Sep 14; 301(3):C630-45. PubMed ID: 21562305 [Abstract] [Full Text] [Related]
12. Suppression of GSK-3β activation by M-cadherin protects myoblasts against mitochondria-associated apoptosis during myogenic differentiation. Wang Y, Hao Y, Alway SE. J Cell Sci; 2011 Nov 15; 124(Pt 22):3835-47. PubMed ID: 22114306 [Abstract] [Full Text] [Related]
13. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts. Conejo R, Lorenzo M. J Cell Physiol; 2001 Apr 15; 187(1):96-108. PubMed ID: 11241354 [Abstract] [Full Text] [Related]
20. Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways. Chen C, Chang YC, Lan MS, Breslin M. Int J Oncol; 2013 Mar 15; 42(3):1113-9. PubMed ID: 23354006 [Abstract] [Full Text] [Related] Page: [Next] [New Search]